Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07010016 · ClinicalTrials.gov registry record · NA
Neuromodulation in Substance Use Disorders
A NA study of Substance Use Disorder, sponsored by Manish Ranjan.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07010016: Active NA study of Substance Use Disorder, sponsored by Manish Ranjan.
NCT07010016 is a NA study of Substance Use Disorder that is active but no longer recruiting, run by Manish Ranjan. The registered enrollment target is 20 participants, below the 821-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07010016, a NA study of Substance Use Disorder, is active but no longer recruiting, sponsored by Manish Ranjan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to assess the safety and feasibility of FUS neuromodulation in participants with OUD and/or other SUDs.
Primary Outcome
Incidence of Investigational procedure and device-related adverse Incidence of Investigational procedure and device-related adverse events and SAEs
Conditions Studied
Interventions
- DEVICE NaviFus Model101
Study Locations (1)
West Virginia
- WVU Rockefeller Neuroscience Institute - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-08-07 |
| Est. Completion | 2028-07-30 |
| Phase | NA |
What the registry record for NCT07010016 still lists
NCT07010016 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 821-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Substance Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which NaviFus Model101 is the first listed.
NCT07010016 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT07010016 about?
NCT07010016 is a clinical study titled "Neuromodulation in Substance Use Disorders". The primary objective of this study is to assess the safety and feasibility of FUS neuromodulation in participants with OUD and/or other SUDs.
What is the current status of trial NCT07010016?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-08-07. Estimated completion is 2028-07-30.
What conditions does trial NCT07010016 study?
This clinical trial studies the following conditions: Substance Use Disorder.
What interventions are being tested in trial NCT07010016?
The interventions under investigation include: NaviFus Model101 (DEVICE).
Who is sponsoring clinical trial NCT07010016?
This trial is sponsored by Manish Ranjan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07010016 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07010016's enrollment target sits among peer trials
20 18th of 18 the lowest of 18 other Substance Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation CM for Veterans With or at Risk for Cancer
RECRUITING · NA
-
A Type I Hybrid Effectiveness-Implementation Trial of MIO
RECRUITING · NA
-
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
RECRUITING · NA
-
Personalized Approach to Healthy Use and Recovery (PATH) Trial
RECRUITING · NA
-
Defining Neurobiological Links Between Substance Use and Mental Illness
RECRUITING · NA
-
Successful Transitions and Reintegration Tools for Veterans (START-VETS)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI